Align Technology (NAS:ALGN) ROCE %

: 17.34% (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Align Technology's annualized ROCE % for the quarter that ended in Jun. 2023 was 17.34%.

Align Technology ROCE % Historical Data

The historical data trend for Align Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Align Technology Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

35.29

35.60

15.38

25.96

16.27

Align Technology Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %																18.62	14.17	12.22	13.49	17.34

Align Technology ROCE % Calculation

Align Technology's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	654.048	/	( ( (5942.11 - 1924.071)	+	(5947.947 - 1925.887) )	/ 2 )
	=	654.048	/	( (4018.039	+	4022.06)	/ 2 )
	=	654.048	/	4020.0495
	=	16.27 %

Align Technology's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	687.724	/	( ( (5901.448 - 2004.598)	+	(6144.55 - 2107.065) )	/ 2 )
	=	687.724	/	( ( 3896.85	+	4037.485 )	/ 2 )
	=	687.724	/	3967.1675
	=	17.34 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

Align Technology (NAS:ALGN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Align Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Align Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology (NAS:ALGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (NAS:ALGN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ALGN:Mexico AFW:Germany AFW:Germany AFW:Germany A1LG34:Brazil ALGN:Austria

Address

410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281

Website

https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.

Executives

Anne Myong	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95141
Kevin J Dallas	director	C/O ALIGN TECHNOLOGY INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95134
Susan E Siegel	director	3000 SAND HILL ROAD, BLDG 3 STE 290, MENLO PARK CA 94025
Markus Christof Sebastian	officer: SVP & Mng Dir EMEA	2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Pudipeddi Vamsi Mohan Raj	officer: SVP, Chief Marketing Officer	2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Julie Ann Coletti	officer: SVP, Chief Legal & Regulatory	2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Warren S Thaler	director	C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Joseph Lacob	director	2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Yuval Shaked	officer: SVP and Mgng Director, Itero	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Lynn Pendergrass	officer: VP, Americas	3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Stuart A Hockridge	officer: VP, Global Human Resources	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
John Morici	officer: Chief Financial Officer	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Sreelakshmi Kolli	officer: VP, Info Technology	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Jennifer Olson	officer: VP& Mng Dir. D-DCC	C/O ALIGN TECHNOLOGY, INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Jennifer Erfurth	officer: VP, Global HR	C/O ALIGN TECHNOLOGY, INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95131